Suicide Deaths Among Adolescent and Young Adult Patients With Cancer
Koji Matsuo,Christina J. Duval,Briana A. Nanton,Jennifer A. Yao,Erin Yu,Christian Pino,Jason D. Wright
DOI: https://doi.org/10.1001/jamanetworkopen.2024.42964
2024-11-05
JAMA Network Open
Abstract:The overall cancer incidence among adolescent and young adult (AYA) patients is increasing at an alarming rate in the US largely driven by thyroid cancer. 1 Although cancer mortality continues to decrease among AYA patients, 1 those who survive cancer are at elevated risk for emotional distress, mental health problems, and suicide. 2 A prior investigation has demonstrated that the number of suicide-related deaths increased among AYA patients with cancer from 1973 to 2015. 3 Given the increasing rate of mental health problems, more contemporaneous data for AYA patients with cancer are urgently needed. This study evaluates differences in suicide rates across age groups of patients with cancer over time in the US. Details of this cohort study are described in the eMethods and eTable in Supplement 1. Briefly, this cohort study queried the National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program 4 to assess suicide deaths among 4 475 284 deaths from 2000 to 2021. Temporal trends of suicide death rates among deceased patients were assessed according to age and sex. The ethical committee of the University of Southern California exempted institutional review board approval because the NCI SEER Program provided and is the source of the deidentified data used; race and ethnicity, which followed identification provided by the NCI SEER database, were grouped by the program, and the program has not verified and is not responsible for the statistical validity of the data analysis or the conclusions derived by the study team. This study followed the STROBE reporting guideline, and IBM SPSS, version 29.0 was used for statistical analysis. A 2-sided P < .05 was defined as statically significant. At the cohort level, the median age at cancer diagnosis was 72 years (IQR, 62-80 years). Most patients were non-Hispanic White (3 323 503 of 4 475 284 [74.3%]). More deaths were recorded for male patients compared with female patients (54.3% vs 45.7%). Among 82 malignant neoplasms, the lung and bronchus were the most frequent sites reported (880 748 of 4 475 284 [19.7%]). At the cohort level, 11 902 suicide deaths were reported (2.7 per 1000 deaths or 1 in 376 deaths). The suicide death rate was highest in the AYA (aged 15-39 years) male patient group among 6 sex- or age-stratified groups (9.0 per 1000 deaths), followed by the adult (aged 40-59 years) male patient group (5.7 per 1000), the AYA female patient group (4.5 per 1000), the older adult (aged ≥60 years) male patient group (3.7 per 1000), the adult female patient group (2.4 per 1000), and the older adult female patient group (0.5 per 1000) ( P < .001). Suicide death rates increased in all 6 groups (Figure). However, the AYA male patient group exhibited the highest suicide death rate throughout the study period from 4.9 to 15.4 per 1000 deaths in 2000 and 2021 ( P < .001 for trend). The gap between the AYA male patient group and the other patient groups widened over time (4.9 vs 0.4-3.1 per 1000 deaths in 2000 and 15.4 vs 0.6-7.4 per 1000 deaths in 2021) (Figure). Among those who had suicide deaths, the median time from cancer diagnosis to suicide deaths in the AYA groups (71 and 67 months for the AYA female and AYA male patient groups, respectively) was longer than the other age groups (range, 30-54 months; P < .001). A total of 456 sex- or age-stratified types of malignant neoplasms were assessed for suicide deaths among deceased patients. The proportion of suicide deaths exceeded 1% in nearly 30% of reported types malignant neoplasms in the AYA male patient group (22 of 74 [29.7%]), followed by the adult male patient group (12 of 62 [16.2%]) and the AYA female patient group (11 of 78 [14.1%]). When further evaluated for specific type of malignant neoplasm (Table), there were 5 types in which the proportion of suicide deaths exceeded 2%, of which 4 of 5 (80%) were in AYA patient groups: AYA female patients with thyroid cancer (38.7 per 1000 deaths), AYA male patients with thyroid cancer (36.6 per 1000 deaths), AYA male patients with testicular cancer (36.3 per 1000 deaths), and AYA male patients with cutaneous melanoma (24.4 per 1000 deaths). Increasing trends of suicide death among AYA patients with cancer observed in this study period extending to the early 2020s add important information because a prior investigation ended in the mid-2010s. 3 Because sex-specific trends among AYA patients with cancer were not examined previously, 3 the rapidly increasing suicide death rate among AYA male patients with cancer is alarming. In 2021, 1 in 65 deaths were attributed to suicide in this group. Key limitations in this study included lack of information about mental health conditions, including suicidal ideation, past suicide attempts, malignancy status such as disease recurrence or remission -Abstract Truncated-
medicine, general & internal